Found 8 matching trials
A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation PHASE2 This study is to assess the safety of a potential new drug DU-176b for the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE N/A The objective of this registry is the characterization of patients with atr...
Show More Location
CIUSSS de l'Estrie-CHUS-Centre Haute-Yamaska-hôpital de Granby
Learn More & Join Trial
Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement PHASE2 Patients who undergo total hip replacement surgery are at greater risk of g...
Show More Location
Local Institution
Learn More & Join Trial
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation PHASE3 This study is to demonstrate the safety and efficacy profile, in two differ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment PHASE3 To assess the safety and pharmacokinetics of DU-176b administered to non-va...
Show More Location
Tokyo Women's Medical University Hospital
Learn More & Join Trial
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs PHASE3 To assess the safety and pharmacokinetics of DU-176b administered to patien...
Show More Location
Toyooka Chuo Hospital
Learn More & Join Trial
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty PHASE2 The objective of this study is to compare the efficacy, safety of DU-176b 3...
Show More Location
Multiple Locations
Learn More & Join Trial
Edoxaban for TIA and Acute Minor Stroke PHASE2 Transient ischemic attack (TIA) or minor ischemic stroke has a high risk of...
Show More Learn More & Join Trial